Impact of assisted reproductive technologies: a mitochondrial perspective of cytoplasmic transplantation.
Many of the assisted reproductive techniques associated with maternal aging, disease states, or implantation failure aim to correct poor developmental capacity. These techniques are highly invasive and require the exchange of nuclear or cytoplasmic material from a donor oocyte to compensate for deficiencies inherent in the affected individual. These techniques are based on the assumption that the cytoplasm of the donor oocyte can effectively substitute the necessary component(s) to enable development to proceed. Several studies have attempted to inject cytoplasm from "normal" (young) donors, into aged eggs, again assuming that beneficial components of the cytoplasm are transferred to restore developmental capacity. These invasive assisted reproduction technology (ART) procedures aim to eliminate chromosomal abnormalities, improve the quality of oocytes deficient in some important cytoplasmic factors necessary for maturation and/or subsequent development, and eliminate maternally inherited diseases (particularly mitochondrial myopathies). However, in order to develop such ART, understanding the processes involving mitochondrial DNA replication and transcription is imperative, as asynchrony between mitochondrial and nuclear genomes may cause problems in mitochondrial function, localization, and biogenesis.
Harvey
A J
AJ
Department of Biology, University of New Orleans New Orleans, Louisiana 70148, USA.
Gibson
T C
TC
Quebedeaux
T M
TM
Brenner
C A
CA
D000818:Animals; D003593:Cytoplasm / Q000637:transplantation*; D004272:DNA, Mitochondrial / Q000235:genetics; D006801:Humans; D007246:Infertility / Q000628:therapy; D008928:Mitochondria / Q000235:genetics / Q000378:metabolism*; D028361:Mitochondrial Diseases / Q000235:genetics / Q000378:metabolism / Q000628:therapy; D027724:Reproductive Techniques, Assisted
D004272:DNA, Mitochondrial